Common diabetes drug promising against rare childhood brain tumor in laboratory studies

Metformin, a drug commonly prescribed against diabetes, holds promise against a rare type of childhood brain tumor in laboratory studies, an international team of researchers led by the University of Michigan Health Rogel Cancer Center report in Science Translational Medicine.

Read more: https://labblog.uofmhealth.org/lab-report/common-diabetes-drug-promising-against-rare-childhood-brain-tumor-laboratory-studies